A Scale-Up To 2000L, Blindfolded!
May 9, 2019 - 11:00 AM Eastern Daylight Time.
Flexibility and speed are key for the development of a new drug, from research to clinic and from clinic to market. Being able to produce a batch at the right time and at the right size is required to handle clinical trials in a fast and cost effective manner. For that purpose, a robust process is mandatory but its scalability makes a difference. During this session, we will describe our method to ensure efficient process tech transfer from a 3L to a 2000L bioreactor, straight forward. The knowledge generated during process development, as well as a specific model designed to keep the oxygen mass transfer coefficient (KLa) stable in any bioreactor, drive the success of such a challenge.
This website uses cookies to ensure you get the best experience on our website. Learn more